A novel outpatient regimen in management of fluoropyrimidine-induced cardiotoxicity.
Saved in:
| Title: | A novel outpatient regimen in management of fluoropyrimidine-induced cardiotoxicity. |
|---|---|
| Authors: | Kasi A; Medical Oncology, The University of Kansas Medical Center, Kansas City, Kansas, USA., Gaudel P; Hematology-Oncology Physician, Cancer Care Specialists of Illinois, Decatur, USA., Lekkala M; Hematology-Oncology Physician, The University of Kansas Cancer Center at St Francis Campus, Kansas, USA., Al-Rajabi R; Medical Oncology, The University of Kansas Medical Center, Kansas City, Kansas, USA., Saeed A; Medical Oncology, The University of Kansas Medical Center, Kansas City, Kansas, USA., Sun W; Medical Oncology, The University of Kansas Medical Center, Kansas City, Kansas, USA., Porter C; Cardiovascular Medicine, The University of Kansas Medical Center, Kansas City, Kansas, USA. |
| Source: | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2023 Dec; Vol. 29 (8), pp. 1951-1956. Date of Electronic Publication: 2023 Mar 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-092X |
|---|---|
| DOI: | 10.1177/10781552231161822 |
